Exploring the Flexibility of the Glycopeptide Antibiotic Crosslinking Cascade for Extended Peptide Backbones
ChemBioChem · 2023
DOI: 10.1002/cbic.202200686 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Y T Candace Ho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Glycopeptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University, EMBL Australia, Australian Research Council.
Abstract (Originalsprache)
The glycopeptide antibiotics (GPAs) are a clinically approved class of antimicrobial agents that classically function through the inhibition of bacterial cell‐wall biosynthesis by sequestration of the precursor lipid II. The oxidative crosslinking of the core peptide by cytochrome P450 (Oxy) enzymes during GPA biosynthesis is both essential to their function and the source of their synthetic challenge. Thus, understanding the activity and selectivity of these Oxy enzymes is of key importance for the future engineering of this important compound class. Recent reports of GPAs that display an alternative mode of action and a wider range of core peptide structures compared to classic lipid II‐binding GPAs raises the question of the tolerance of Oxy enzymes for larger changes in their peptide substrates. In this work, we explore the ability of Oxy enzymes from the biosynthesis pathways of lipid II‐binding GPAs to accept altered peptide substrates based on a vancomycin template. Our results show that Oxy enzymes are more tolerant of changes at the N terminus of their substrates, whilst C‐terminal extension of the peptide substrates is deleterious to the activity of all Oxy enzymes. Thus, future studies should prioritise the study of Oxy enzymes from atypical GPA biosynthesis pathways bearing C‐terminal peptide extension to increase the substrate scope of these important cyclisation enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
- EMBL Australia, Monash University, Clayton, VIC 3800, Australia.
- ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, VIC 3800, Australia.
- Monash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC 3800, Australia.
- Interfaculty Institute of Microbiology and Infection Medicine, Cluster of Excellence 'Controlling Microbes to Fight Infections', University of Tübingen, 72076, Tübingen, Germany.
ORCID-Profile: Y T Candace Ho, Julien Tailhades, Max J Cryle
Förderung
- Monash University
- EMBL Australia
- Australian Research Council
- Australian Government
Zitieren
APA
Ho, Y. T. C., Schittenhelm, R. B., Iftime, D., Stegmann, E., Tailhades, J., & Cryle, M. J. (2023). Exploring the Flexibility of the Glycopeptide Antibiotic Crosslinking Cascade for Extended Peptide Backbones. ChemBioChem. https://doi.org/10.1002/cbic.202200686
Vancouver
Ho YTC, Schittenhelm RB, Iftime D, Stegmann E, Tailhades J, Cryle MJ. Exploring the Flexibility of the Glycopeptide Antibiotic Crosslinking Cascade for Extended Peptide Backbones. ChemBioChem. 2023. doi:10.1002/cbic.202200686
BibTeX
@article{Ho2023,
author = {Ho, Y T Candace and Schittenhelm, Ralf B and Iftime, Dumitrita and Stegmann, Evi and Tailhades, Julien and Cryle, Max J},
title = {Exploring the Flexibility of the Glycopeptide Antibiotic Crosslinking Cascade for Extended Peptide Backbones},
journal = {ChemBioChem},
year = {2023},
doi = {10.1002/cbic.202200686}
}
EUVIMED